- Home
- SLRX vs SNES Comparison
SLRX vs SNES Comparison
Compare SLRX & SNES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRX
- SNES
- Stock Information
- Founded
- SLRX N/A
- SNES 2004
- Country
- SLRX United States
- SNES United States
- Employees
- SLRX N/A
- SNES N/A
- Industry
- SLRX Biotechnology: Pharmaceutical Preparations
- SNES Agricultural Chemicals
- Sector
- SLRX Health Care
- SNES Industrials
- Exchange
- SLRX Nasdaq
- SNES Nasdaq
- Market Cap
- SLRX 2.1M
- SNES 2.3M
- IPO Year
- SLRX N/A
- SNES 2016
- Fundamental
- Price
- SLRX $1.70
- SNES $3.54
- Analyst Decision
- SLRX
- SNES Strong Buy
- Analyst Count
- SLRX 0
- SNES 1
- Target Price
- SLRX N/A
- SNES $10.00
- AVG Volume (30 Days)
- SLRX 98.7K
- SNES 339.6K
- Earning Date
- SLRX 11-14-2024
- SNES 02-19-2025
- Dividend Yield
- SLRX N/A
- SNES N/A
- EPS Growth
- SLRX N/A
- SNES N/A
- EPS
- SLRX N/A
- SNES N/A
- Revenue
- SLRX N/A
- SNES $1,651,000.00
- Revenue This Year
- SLRX N/A
- SNES $76.36
- Revenue Next Year
- SLRX N/A
- SNES $103.47
- P/E Ratio
- SLRX N/A
- SNES N/A
- Revenue Growth
- SLRX N/A
- SNES 38.16
- 52 Week Low
- SLRX $1.22
- SNES $1.90
- 52 Week High
- SLRX $7.20
- SNES $14.40
- Technical
- Relative Strength Index (RSI)
- SLRX 56.15
- SNES 61.95
- Support Level
- SLRX $1.52
- SNES $3.02
- Resistance Level
- SLRX $2.06
- SNES $3.58
- Average True Range (ATR)
- SLRX 0.18
- SNES 0.59
- MACD
- SLRX 0.03
- SNES 0.03
- Stochastic Oscillator
- SLRX 57.14
- SNES 39.17
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.